company logo

Medical Director, Clinical Science, Gene Therapy for Hemophilia A in San Rafael, CA

BioMarin Pharmaceutical

San Rafael, CA 94901
7w ago
Save

specialty:

Life Sciences

experience:

Less than 5 years

Job Description

BioMarin is the world leader in delivering therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. We target diseases that lack effective therapies and affect relatively small numbers of patients, many of whom are children. These conditions are often inherited, difficult to diagnose, progressively debilitating and have few, if any, treatment options. BioMarin will continue to focus on advancing therapies that are the first or best of their kind.


BioMarin's Research & Development group is responsible for everything from research and discovery to post-market clinical development. Research & Development involves all bench and clinical research and the associated groups that support those endeavors. Our teams work on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with rare diseases. Come join our team and make a meaningful impact on

See More

Valid through: 2020-2-22

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarins core business and research is in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I (MPS I), by manufacturing laronidase (Aldurazyme, commercialized by Genzyme Corporation). BioMarin was also the first company to provide therapeutics for phenylketonuria (PKU). BioMarin was founded in 1997 by Christopher Starr Ph.D. and Grant W. Denison Jr. with an investment of a $1.5 million from Glyko Biomedical and went public in 1999. Seed investors were amongst others MPM Bioventures, Grosvenor Fund and Florian Schönharting. In 2002, BioMarin acquired Glyko Biomedical.
Total Jobs:
85
Total Experts:
5
Average Pay:
$141,666
Total value of jobs:
$11,900,000
% Masters:
43%

BioMarin Pharmaceutical Inc. Photos

company social media photocompany social media photocompany social media photocompany social media photo
* Ladders Estimates